SCHEMBL10973640

SCHEMBL10973640

O=c1c2nccnc2n(CC2CO2)c(=O)n1CC1CO1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.52
▸ HBB P68871 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ TNF P01375 7/20 0.40
▸ DHFR P00374 1/20 0.36
▸ CDK4 P11802 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ CCND2 P30279 1/20 0.34
▸ CCND3 P30281 1/20 0.34
▸ TSHR P16473 4/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ PDE5A O76074 2/20 0.32
▸ PDE4A P27815 2/20 0.32
▸ PDE4B Q07343 2/20 0.32
▸ PDE4C Q08493 2/20 0.32
▸ PDE4D Q08499 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ TRPA1 O75762 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10977463 0.74 TP53 (0.46) TP53HBBSMN1; SMN2DHFRCDK4
SCHEMBL11355379 0.73 TP53 (0.49) TP53HBBSMN1; SMN2PDE4APDE4B
Teroxirone SCHEMBL4470513 0.71 TP53 (1.00) TP53HBBSMN1; SMN2DHFRCDK4
Teroxirone SCHEMBL4461477 0.71 TP53 (1.00) TP53HBBSMN1; SMN2DHFRCDK4
Teroxirone SCHEMBL4472568 0.71 TP53 (1.00) TP53HBBSMN1; SMN2DHFRCDK4
Teroxirone SCHEMBL2097375 0.71 TP53 (1.00) TP53HBBSMN1; SMN2DHFRCDK4
Teroxirone SCHEMBL2097151 0.71 TP53 (1.00) TP53HBBSMN1; SMN2DHFRCDK4
Teroxirone SCHEMBL4452999 0.71 TP53 (1.00) TP53HBBSMN1; SMN2DHFRCDK4
Teroxirone SCHEMBL4932 0.71 TP53 (1.00) TP53HBBSMN1; SMN2DHFRCDK4
SCHEMBL5435485 0.70 TNF (0.53) SMN1; SMN2TNFTSHRALDH1A1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4463006-A ANTICANCER, ANTITUMOR AGENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1984-07-31 — — US claimed
EP-0071903-B1 DIGLYCIDYL PTERIDINE COMPOUNDS, METHOD FOR THEIR PREPARATION AND THEIR USE IN DRUGS WITH A CYTOSTATIC ACTIVITY Henkel Kommanditgesellschaft auf Aktien (DE) 1985-08-28 — — EP disclosed
US-4463006-A ANTICANCER, ANTITUMOR AGENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1984-07-31 — — US disclosed
EP-0071903-A1 Diglycidyl pteridine compounds, method for their preparation and their use in drugs with a cytostatic activity Henkel Kommanditgesellschaft auf Aktien (DE) 1983-02-16 — — EP disclosed
Send feedback